drugset / Trial / NCT02201511
A Healthy Volunteer Trial to Gain Information About the Blood Concentrations of PF-06412562 After Oral Administration of a Modified Release Formulation in Fasted and Fed Conditions
RandomizedCrossoverOpen-labelBasic science
Summary
The study is designed to understand the blood concetration of PF-06412562 and its metabolite, PF-06663872, following a single oral dose of a modified release formulation. The study will include two doses of the PF-06412562 modified release formulation to understand the proportionality. Effect of food on absorption of PF-06412562 from the modified release formulation will also be investigated in this study.
Timeline
- Start
- 2014-09
- Primary completion
- 2014-10
- Completion
- 2014-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-06412562 | Unknown | 3 mg | Oral |
| Subject | PF-06412562 | Unknown | 10 mg | Oral |
| Subject | PF-06412562 | Unknown | 15 mg | Oral |
Indications
No indication recorded.